{"id":"W4238548979","doi":"10.1007/s40274-021-7747-3","title":"Ribociclib + NSAI may be cost effective for advanced breast cancer in Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quality of Life Research; Breast cancer; Cancer; Medicine; Public health; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004399463,0.000181632,0.0002820489,0.0005245046,0.0007541397,0.00154164,0.0006062337,0.0007642658,0.01669674],"category_scores_gemma":[0.003362422,0.0001488568,0.0007253168,0.001142265,0.0004780247,0.0003933483,0.0003143792,0.001552142,0.0006122578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03670306,"about_ca_system_score_gemma":0.06186159,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9594494,"about_ca_topic_score_gemma":0.9869441,"domain_scores_codex":[0.9994572,0.00005615949,0.00003267349,0.0000341508,0.0002171719,0.0002026461],"domain_scores_gemma":[0.9975181,0.0002607583,0.0001912012,0.00002185698,0.0008903792,0.001117758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003165333,0.0003178361,0.04694437,0.0009066586,0.000339844,0.0006295201,0.0001462895,0.002838979,0.001145638,0.006735595,0.6407679,0.2960619],"study_design_scores_gemma":[0.004180904,0.0009699492,0.2924707,0.001605241,0.001144184,0.0007226869,0.001159999,0.005933268,0.001234307,0.003738551,0.6867003,0.0001399525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.1980457,0.05562014,0.000649185,0.5505353,0.004366201,0.000350198,0.02321696,0.0004939502,0.1667225],"genre_scores_gemma":[0.7919285,0.06002248,0.002007712,0.0692855,0.003274103,0.0001255441,0.0116855,0.0001449725,0.06152578],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.04055059,"threshold_uncertainty_score":0.2663006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01547059712369795,"score_gpt":0.3594825584680343,"score_spread":0.3440119613443363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}